Integrase Defective Lentiviral Vector as a Vaccine Platform for Delivering Influenza Antigens

Integrase Defective Lentiviral Vector as a Vaccine Platform for Delivering Influenza Antigens

Viral vectors represent an attractive technology for vaccine delivery. We exploited the integrase defective lentiviral vector (IDLV) as a platform for delivering relevant antigens within the context of the ADITEC collaborative research program. In particular, Influenza virus hemagglutinin (HA) and n...

Full description

Bibliographic Details
Main Authors: Alessandra Gallinaro, Martina Borghi, Roberta Bona, Felicia Grasso, Laura Calzoletti, Laura Palladino, Serena Cecchetti, Maria Fenicia Vescio, Daniele Macchia, Valeria Morante, Andrea Canitano, Nigel Temperton, Maria Rita Castrucci, Mirella Salvatore, Zuleika Michelini, Andrea Cara, Donatella Negri
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-02-01
Series:Frontiers in Immunology
Subjects:
lentiviral vector
influenza
vaccine
antibody
T cell response
Online Access:http://journal.frontiersin.org/article/10.3389/fimmu.2018.00171/full

Internet

http://journal.frontiersin.org/article/10.3389/fimmu.2018.00171/full

Similar Items